| Recruitment status | Main results already published |
| Unique ID issued by UMIN | UMIN000027651 |
| Receipt No. | R000031675 |
| Scientific Title | The study of total tear and specific serum IgE in patients with allergic conjunctivitis |
| Date of disclosure of the study information | 2017/08/01 |
| Last modified on | 2019/12/09 (Ver. 6) |
| Basic information | ||
| Public title | The study of total tear and specific serum IgE in patients with allergic conjunctivitis | |
| Acronym | The study of total tear and specific serum IgE | |
| Scientific Title | The study of total tear and specific serum IgE in patients with allergic conjunctivitis | |
| Scientific Title:Acronym | The study of total tear and specific serum IgE | |
| Region |
|
|
| Condition | ||
| Condition | allergic conjunctivitis | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | We have routinely examined suspected allergic conjunctivitis using the inspection methods of total tear IgE test and specific serum IgE test based on the current standard guildlines for the clinical management of allergic conjunctival diseases (2010, 2nd edition) of the Japanese Ophthalmology Society.
We have found notable divergence between findings in our cases and those findings suggested by the guidelines. Therefore, like the local allergic rhinitis described in 2016 in the Otolaryngology Guideline, this study aims to ascertain whether there is a certain proportion of local allergic conjunctivitis and non-IgE type local allergic conjunctivitis. |
| Basic objectives2 | Others |
| Basic objectives -Others | Prevalence of Local Allergic Conjunctivitis |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | The prevalence of local allergic conjunctivitis and non-IgE type local allergic conjunctivitis
The percentage of cases diagnosed as local allergic conjunctivitis and non-IgE type local allergic conjunctivitis in the group to be analyzed |
| Key secondary outcomes | 1.The distribution of the result of total tear IgE test and specific serum IgE test: the percentage of positive and negative cases of specific serum IgE test in positive and negative cases of total tear IgE test
2.The ratio of eosinophils in conjunctival scraping specimens: the percentage of positive cases of eosinophils in conjunctival craping specimens in the group to be analyzed 3.Relation between the precalence of local allergic conjunctivitis and non-IgE type local allergic conjunctivitis and background factor 4.Relation between each prevalence and the following background factor: age and sex |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1. the patients who visited in Yamana Eye Clinic on Dec. 1, 2013 to March 31, 2017
2. the patients complaining of allergic symptoms such as eye itching, discomfort, congestion, swelling and stuffy nose |
|||
| Key exclusion criteria | The patients without total tear IgE test and specific serum IgE test | |||
| Target sample size | 148 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | Yamana Eye Clinic | ||||||
| Division name | Ophthalmology | ||||||
| Zip code | 809-0022 | ||||||
| Address | 13-5 Nabeyama-machi Nakama Fukuoka, Japan | ||||||
| TEL | 093-246-2345 | ||||||
| yamanaganka@yamana.or.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | Yamana Eye Clinic | ||||||
| Division name | Ophthalmology | ||||||
| Zip code | 809-0022 | ||||||
| Address | 13-5 Nabeyama-machi Nakama Fukuoka, Japan | ||||||
| TEL | 093-246-2345 | ||||||
| Homepage URL | |||||||
| yamanaganka@yamana.or.jp | |||||||
| Sponsor | |
| Institute | Yamana Eye Clinic |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Clinical Research Network Fukuoka |
| Address | 3-1-1 Maidashi Higashi-ku Fukuoka, Fukuoka, Japan |
| Tel | 092-643-7171 |
| mail@crnfukuoka.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Published |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | 148 |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Main results already published | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | Observation items;
1. Patients background information: age, sex, medical history, prescription drugs, symptoms 2. clinical examination: findings of eyelid, palpebral conjunctiva, ocular conjunctiva, corneal by slit lamp microscope Total tear IgE test (Allerwatch tear IgE), specific serum IgE test (immunoCAP rapid and View allergy 39), palpebral conjunctiva, microscopic examination by Eosinostein staining 3. diagnostic imaging; slit lamp micrograph, photograph of fundus 4. Questionnaire: Japanese Allergic Conjunctivitis standard QOL questionnaire ver.1 Factors to consider Allergic testing case: among the subjects to be studies, the cases in which total tear IgE test and specific serum IgE test were performed. Local allergic conjunctivitis cases: the cases where allergens could not be identified by specific serum IgE test, despite positive in total tear IgE test. Non-IgE type local allergic conjunctivitis: negative in total tear IgE test, and allergen could not be identified by specific serum IgE test, but the cases with eosinophils confirmed by palpebral conjunctiva rubbing. |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000031675 |